These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19450748)

  • 1. Transplantation conditioning regimens: can we say it better?
    Deeg HJ
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):653-5. PubMed ID: 19450748
    [No Abstract]   [Full Text] [Related]  

  • 2. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current European practice in pediatric myeloablative conditioning.
    Vettenranta K;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S14-7. PubMed ID: 18545236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.
    Ulrickson M; Aldridge J; Kim HT; Hochberg EP; Hammerman P; Dube C; Attar E; Ballen KK; Dey BR; McAfee SL; Spitzer TR; Chen YB
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1447-54. PubMed ID: 19822305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Total body irradiation: present and future].
    Zilli T; Miralbell R; Ozsahin M
    Cancer Radiother; 2009 Sep; 13(5):428-33. PubMed ID: 19615929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treosulphan as an alternative to busulphan for myeloablative conditioning in paediatric allogeneic transplantation.
    Cutting R; Mirelman A; Vora A
    Br J Haematol; 2008 Dec; 143(5):748-51. PubMed ID: 19036020
    [No Abstract]   [Full Text] [Related]  

  • 9. Concepts, categories, and value judgments in informed consent forms.
    Hochhauser M
    IRB; 2003; 25(5):7-10. PubMed ID: 14870727
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward a construct definition of informed consent comprehension.
    Buccini LD; Caputi P; Iverson D; Jones C
    J Empir Res Hum Res Ethics; 2009 Mar; 4(1):17-23. PubMed ID: 19382877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.
    Al-Ali H; Cross M; Lange T; Freund M; Dölken G; Niederwieser D
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S17-22. PubMed ID: 19561407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.
    Ringdén O; Labopin M; Ehninger G; Niederwieser D; Olsson R; Basara N; Finke J; Schwerdtfeger R; Eder M; Bunjes D; Gorin NC; Mohty M; Rocha V
    J Clin Oncol; 2009 Sep; 27(27):4570-7. PubMed ID: 19652066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the Tasman trial?
    Cheng TO
    Thromb Haemost; 1998 Apr; 79(4):884. PubMed ID: 9569214
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review.
    Pollack SM; O'Connor TP; Hashash J; Tabbara IA
    Am J Clin Oncol; 2009 Dec; 32(6):618-28. PubMed ID: 19593085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulnerability: too vague and too broad?
    Schroeder D; Gefenas E
    Camb Q Healthc Ethics; 2009 Apr; 18(2):113-21. PubMed ID: 19250564
    [No Abstract]   [Full Text] [Related]  

  • 17. Sirolimus-containing graft-versus-host disease prophylaxis in patients with lymphoma.
    Mehta J
    J Clin Oncol; 2009 Oct; 27(28):e138; author reply e139-40. PubMed ID: 19720890
    [No Abstract]   [Full Text] [Related]  

  • 18. Why does informed consent fail? A discourse analytic approach.
    Ness DE; Kiesling SF; Lidz CW
    J Am Acad Psychiatry Law; 2009; 37(3):349-62. PubMed ID: 19767500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination regimens using doxorubicin and pegylated liposomal doxorubicin prior to autologous transplantation in multiple myeloma.
    Moreau P
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):885-90. PubMed ID: 19589027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A consent form template for phase I oncology trials.
    Koyfman SA; McCabe MS; Emanuel EJ; Grady C
    IRB; 2009; 31(4):1-8. PubMed ID: 19697538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.